Plants and methods for producing muconic acid
The present invention provides for a genetically modified plant or plant cell comprising a nucleic acid encoding one or more heterologous enzymes operatively linked a promoter, wherein one or more heterologous enzymes synthesizes muconic acid (MA).
1. A genetically modified plant or plant cell which endogenously produces salicyclic acid comprising a first nucleic acid encoding a plastid transit peptide linked to a heterologous salicylate hydroxylase (NahG), a second nucleic acid encoding a plastid transit peptide linked to a heterologous catechol 1,2-dioxygenase (CatA), which synthesize muconic acid (MA), a third nucleic acid encoding a plastid transit peptide linked to a heterologous bifunctional ISOCHA synthase/ISOCHA pyruvate lyase (Irp9) operatively linked to a promoter, and a fourth nucleic acid encoding a plastid transit peptide linked to a heterologous a feedback-resistant DAHP synthase (L175Q) (AroG*);
wherein the genetically modified plant or plant cell produces a MA titer with an at least 39-fold increase compared to a MA titer of a plant or plant cell modified only with the first nucleic acid encoding a plastid transit peptide linked to a heterologous salicylate hydroxylase (NahG), and a second nucleic acid encoding a plastid transit peptide linked to a heterologous catechol 1,2-dioxygenase (CatA), and the genetically modified plant or plant cell produces a MA titer of at least 483 μg/g DW; wherein the genetically modified plant cell or plant is of an Arabidopsis or Populus species.
2. The genetically modified plant or plant cell of claim 1 , wherein the salicylate hydroxylase (NahG) is a bacterial salicylate hydroxylase (NahG).
3. The genetically modified plant or plant cell of claim 1 , wherein the catechol 1,2-dioxygenase (CatA) is a bacterial catechol 1,2-dioxygenase (CatA).
4. The genetically modified plant or plant cell of claim 1 , wherein the bifunctional ISOCHA synthase/ISOCHA pyruvate lyase (Irp9) is bacterial or Yersinia enterocolitica bifunctional ISOCHA synthase/ISOCHA pyruvate lyase (Irp9).
5. The genetically modified plant or plant cell of claim 1 , wherein the feedback-resistant DAHP synthase (L175Q) (AroG*) is bacterial or E. coli DAHP synthase (AroG) that has a L175Q mutation which causes the AroG to be feedback resistant.
6. A method for producing a muconic acid comprising: (a) providing a genetically modified plant cell or plant of claim 1 , and (b) growing or culturing the genetically modified plant cell or plant to produce a muconic acid;
wherein the genetically modified plant cell or plant produces a MA titer of at least 483 μg/g DW.
7. The genetically modified plant or plant cell of claim 1 , wherein each plastid transit peptide is a plastid transit peptide from Arabidopsis ferredoxin2 (schl1), a plastid transit peptide from pea ( Pisum sativum ) ribulose-1,5-bisphosphate carboxylase small subunit (schl2), or a plastid transit peptide from sunflower ( Helianthus annuus ) ribulose-1,5-bisphosphate carboxylase small subunit (schl3).
8. The genetically modified plant or plant cell of claim 2 , wherein the bacterial salicylate hydroxylase (NahG) is a Pseudomonas salicylate hydroxylase (NahG).
9. The genetically modified plant or plant cell of claim 3 , wherein the bacterial catechol 1,2-dioxygenase (CatA) is a Pseudomonas catechol 1,2-dioxygenase (CatA).
10. The genetically modified plant or plant cell of claim 4 , wherein the bacterial bifunctional ISOCHA synthase/ISOCHA pyruvate lyase (Irp9) is a Yersinia enterocolitica bifunctional ISOCHA synthase/ISOCHA pyruvate lyase (Irp9).
11. The genetically modified plant or plant cell of claim 5 , wherein the bacterial feedback-resistant DAHP synthase (L175Q) (AroG*) is a E. coli DAHP synthase (AroG) that has a L175Q mutation.
12. The method of claim 6 , wherein the genetically modified plant or plant cell further comprises a third nucleic acid encoding a heterologous bifunctional ISOCHA synthase/ISOCHA pyruvate lyase (Irp9) operatively linked to a promoter, and a fourth nucleic acid encoding a heterologous a feedback-resistant DAHP synthase (L175Q) (AroG*) operatively linked to a promoter.
13. The method of claim 6 , wherein the salicylate hydroxylase (NahG) is a bacterial salicylate hydroxylase (NahG).
14. The method of claim 6 , wherein the catechol 1,2-dioxygenase (CatA) is a bacterial catechol 1,2-dioxygenase (CatA).
15. The method of claim 12 , wherein the bifunctional ISOCHA synthase/ISOCHA pyruvate lyase (Irp9) is bacterial or Yersinia enterocolitica bifunctional ISOCHA synthase/ISOCHA pyruvate lyase (Irp9).
16. The method of claim 12 , wherein the feedback-resistant DAHP synthase (L175Q) (AroG*) is bacterial or E. coli DAHP synthase (AroG) that has a L175Q mutation which causes the AroG to be feedback resistant.
17. The method of claim 12 , wherein the first nucleic acid further encodes a plastid transit peptide linked to NahG, the second nucleic acid further encodes a plastid transit peptide linked to CatA, the third nucleic acid further encodes a plastid transit peptide linked to Irp9, and the fourth nucleic acid further encodes a plastid transit peptide linked to AroG*.
18. The method of claim 17 , wherein each plastid transit peptide is a plastid transit peptide from Arabidopsis ferredoxin2 (schl1), a plastid transit peptide from pea ( Pisum sativum ) ribulose-1,5-bisphosphate carboxylase small subunit (schl2), or a plastid transit peptide from sunflower (Helianthus annuus) ribulose-1,5-bisphosphate carboxylase small subunit (schl3).
19. The method of claim 6 , further comprising (c) pretreating the plant cell or plant, and (d) converting the muconic acid into an adipic acid, terephthalic acid, and/or caprolactam.
20. The method of claim 6 , wherein the genetically modified plant cell or plant produces 3500 to 4500 nmole MA/g FW.
21. The genetically modified plant or plant cell of claim 1 , wherein the genetically modified plant cell or plant is of an Arabidopsis species.
22. The method of claim 6 , wherein the genetically modified plant cell or plant is of an Arabidopsis species.